Daiken Medical Co., Ltd. provided non-consolidated earnings guidance for the year ending March 31, 2023. For the year ending March 31, 2023, the company expects to report net sales of ¥9,000 million, operating profit of ¥1,200 million, and profit of ¥840 million or ¥29.24 per share.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
550 JPY | -1.61% | -0.54% | +7.21% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.21% | 104M | |
+73.64% | 12.42B | |
-19.88% | 7.94B | |
+2.90% | 6.17B | |
+13.65% | 5.5B | |
+40.00% | 5.01B | |
-15.25% | 4.88B | |
-16.42% | 4.2B | |
-28.70% | 2.73B | |
+48.49% | 2.27B |
- Stock Market
- Equities
- 7775 Stock
- News Daiken Medical Co., Ltd.
- Daiken Medical Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Year Ending March 31, 2023